ContextVision presents Q4 and full year 2012

Q4 2012 HIGHLIGHTS

  • Significant sales development
  • Europe strengthened position
  • 3D Ultrasound focus at RSNA in Chicago
  • Product upgrades for Ultrasound, XR, MRI and iRV

Q4 2012 FINANCIAL DATA

  • Sales of 20.5 MSEK (17.2)
  • Operating result of 1.6 MSEK (1.4) and operating margin of 7.8% (7.9%).
  • Earnings per share of 0,20 (0,12) SEK

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit www.contextvision.com.

Subscribe

Documents & Links